JAMA Network Open
Nancy E. Morden, MD, MPH; Weiping Zhou, MS; Ziad Obermeyer, MD, MPhil, PhD; Jonathan Skinner, PhD
Duringthefirst2yearsoftheCOVID-19pandemic,inpatientandambulatorycare declined dramatically. Little is known about prescription drug receipt during this period, particularly for populations with chronic illness and with high risk of adverse COVID-19 outcomes and decreased access to care.